BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23178498)

  • 1. TRF2-mediated telomere protection is dispensable in pluripotent stem cells.
    Markiewicz-Potoczny M; Lobanova A; Loeb AM; Kirak O; Olbrich T; Ruiz S; Lazzerini Denchi E
    Nature; 2021 Jan; 589(7840):110-115. PubMed ID: 33239785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent telomere cohesion protects aged cells from premature senescence.
    Azarm K; Bhardwaj A; Kim E; Smith S
    Nat Commun; 2020 Jul; 11(1):3321. PubMed ID: 32620872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells.
    Qiu YD; Yan Q; Wang Y; Ye YF; Wang Y; Wang MY; Wang PP; Zhang SY; Wang DL; Yan H; Ruan J; Zhao YJ; Huang LH; Cho N; Wang K; Zheng XH; Liu ZG
    Acta Pharmacol Sin; 2024 Jun; 45(6):1276-1286. PubMed ID: 38438580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of TRF2 accelerates telomere attrition and DNA damage in naïve CD4 T cells during HCV infection.
    Nguyen LN; Zhao J; Cao D; Dang X; Wang L; Lian J; Zhang Y; Jia Z; Wu XY; Morrison Z; Xie Q; Ji Y; Zhang Z; El Gazzar M; Ning S; Moorman JP; Yao ZQ
    Cell Death Dis; 2018 Sep; 9(9):900. PubMed ID: 30185784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of TRF2
    Sobinoff AP; Di Maro S; Low RRJ; Benedetti R; Tomassi S; D'Aniello A; Russo R; Baglivo I; Chianese U; Pedone PV; Chambery A; Cesare AJ; Altucci L; Pickett HA; Cosconati S
    Cell Chem Biol; 2023 Dec; 30(12):1652-1665.e6. PubMed ID: 38065101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy.
    Khattar E; Maung KZY; Chew CL; Ghosh A; Mok MMH; Lee P; Zhang J; Chor WHJ; Cildir G; Wang CQ; Mohd-Ismail NK; Chin DWL; Lee SC; Yang H; Shin YJ; Nam DH; Chen L; Kumar AP; Deng LW; Ikawa M; Gunaratne J; Osato M; Tergaonkar V
    Nat Commun; 2019 Dec; 10(1):5349. PubMed ID: 31836706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.
    Rizzo A; Maresca C; D'Angelo C; Porru M; Di Vito S; Salvati E; Sacconi A; Berardinelli F; Sgura A; Kuznetsov S; Potdar S; Hassinen A; Stoppacciaro A; Zizza P; Biroccio A
    Aging Cell; 2023 Nov; 22(11):e13944. PubMed ID: 37858982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere dysfunction alters intestinal stem cell dynamics to promote cancer.
    LaBella KA; Hsu WH; Li J; Qi Y; Liu Y; Liu J; Wu CC; Liu Y; Song Z; Lin Y; Blecher JM; Jiang S; Shang X; Han J; Spring DJ; Zhang J; Xia Y; DePinho RA
    Dev Cell; 2024 Mar; ():. PubMed ID: 38574731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diffused versus vasculature targeted DNA damage on the heart of mice depleted of telomeric factor Ft1.
    La Torre M; Centofante E; Nicoletti C; Burla R; Giampietro A; Cannistrà F; Schirone L; Valenti V; Sciarretta S; Musarò A; Saggio I
    Aging Cell; 2023 Dec; 22(12):e14022. PubMed ID: 37960940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review).
    Wang Z; Wu X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere DNA damage signaling regulates cancer stem cell evolution, epithelial mesenchymal transition, and metastasis.
    Lagunas AM; Wu J; Crowe DL
    Oncotarget; 2017 Oct; 8(46):80139-80155. PubMed ID: 29113290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Atm and Trp53 in neural cell loss due to Terf2 inactivation during mouse brain development.
    Kim J; Choi I; Lee Y
    Histochem Cell Biol; 2017 Nov; 148(5):489-501. PubMed ID: 28620865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HULC cooperates with MALAT1 to aggravate liver cancer stem cells growth through telomere repeat-binding factor 2.
    Wu M; Lin Z; Li X; Xin X; An J; Zheng Q; Yang Y; Lu D
    Sci Rep; 2016 Oct; 6():36045. PubMed ID: 27782152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically.
    Li T; Zheng Q; An J; Wu M; Li H; Gui X; Pu H; Lu D
    Mol Ther; 2016 Feb; 24(2):261-275. PubMed ID: 26581161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Nitropropionic acid induces ovarian oxidative stress and impairs follicle in mouse.
    Zhang JQ; Shen M; Zhu CC; Yu FX; Liu ZQ; Ally N; Sun SC; Li K; Liu HL
    PLoS One; 2014; 9(2):e86589. PubMed ID: 24505260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell expansion during carcinogenesis in stem cell-depleted conditional telomeric repeat factor 2 null mutant mice.
    Bojovic B; Ho HY; Wu J; Crowe DL
    Oncogene; 2013 Oct; 32(43):5156-66. PubMed ID: 23178498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions.
    Nera B; Huang HS; Lai T; Xu L
    Nat Commun; 2015 Dec; 6():10132. PubMed ID: 26640040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic dissection of the mechanisms underlying telomere-associated diseases: impact of the TRF2 telomeric protein on mouse epidermal stem cells.
    Stout GJ; Blasco MA
    Dis Model Mech; 2009; 2(3-4):139-56. PubMed ID: 19259387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion.
    Celli GB; de Lange T
    Nat Cell Biol; 2005 Jul; 7(7):712-8. PubMed ID: 15968270
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.